ERN1 and breast carcinoma: In addition, the RIDD activity of IRE1 can reduce the expression of many tumour suppressor miRNAs, such as miR-34 in acute myeloid leukaemia and miR-3609 in breast cancer, to promote cancer progression [43,44].